Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Stanley Black & Decker, Inc. (SWK) Price & Performance

Royalty Pharma plc Class A Ordinary SharesTrade
Stanley Black & Decker, Inc.Trade

Price performance (Past 24H)

Key statistics

Royalty Pharma plc Class A Ordinary Shares vs Stanley Black & Decker, Inc. — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B), while Stanley Black & Decker, Inc. trades at $88.57 (market cap $13.47B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.77%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Stanley Black & Decker, Inc. for 62 Days on average.

RPRXSWK
Market Cap
$25.27B$13.47B
Volume
3,671,1832,859,744
Sector
HealthIndustrials
52-Week High
$63.96$104.00
52-Week Low
$35.44$62.12
Typical Hold Time
1 Days62 Days
Enterprise Value
$32.50B$17.63B
Dividend Yield
1.66%3.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Stanley Black & Decker, Inc.

Stanley Black & Decker (SWK) trades at $88.57, up 0.29% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with Q2 2026 EPS of $1.57 beating expectations of $1.21, and projected 2026 net income margin of 4.06%. Valuation appears reasonable with P/E of 21.8 and P/S of 0.89. Recent product launches include the dustbuster mini vacuum, while management focuses on margin improvement and DEWALT market share gains.

SWK presents a mixed outlook with analyst consensus at $93.00 (5% upside) but technical indicators signaling caution. The company's dividend king status provides income stability, though operational execution risks and competitive pressures remain concerns. Near-term catalyst includes Q3 2026 earnings release on November 4, 2026, which could validate margin improvement progress.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →

About Stanley Black & Decker, Inc.

Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.

Read more on SWK →